# Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

> **NCT01016626** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CKD-4101 tablet
- **DRUG:** Mycophenolate Mofetil capsule

## Key facts

- **NCT ID:** NCT01016626
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016626, "Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01016626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*